Cordlife

Cordlife swings back to profitability; posts 2Q earnings of $0.74 mil

SINGAPORE (Feb 12): Cordlife Group has swung back to profitability in 2Q18, posting earnings of $0.74 million, compared to a loss of $2.28 million in 2Q17.

Revenue for the quarter came in at $16.4 million, 7.6% higher than $15.2 million a year ago, mainly contributed by India, the Philippines and Singapore.

How clear is Clearbridge Health post-listing outlook?

SINGAPORE (Dec 14): Clearbridge Health (CBH), the healthcare firm which focuses on the delivery of precision medicine, boosts a capable team to lead its expansion across Asia, says Maybank KimEng.

See: Clearbridge Health to list on Catalist; seeking to raise $24.6 million

Cordlife swings back to profitability; posts 1Q earnings of $0.6 mil

SINGAPORE (Nov 9): Cordlife Group has swung back to profitability in 1Q18, posting earnings of $649,000 compared to a loss of $574,000 in 1Q17.

Revenue for the first quarter ended September was 13.2% higher at $16.6 million from $14.7 million a year ago, mainly due to an increase in newborn deliveries to 6,700 in 1Q18 from 6,300 in 1Q17.

The increase in revenue was also partly due to lower discounts given in India and the Philippines in lieu of more value-added services provided to clients in these countries.

Ascendas India Trust, Fragrance, Cordlife, Jumbo, Trendlines

SINGAPORE (Feb 1): Here are some stocks that could move the market this Wednesday morning.

Ascendas India Trust reported a DPU of 1.42 cents for 3Q17, a 5% increase from 3Q16. Total property income rose 7% to IDR 1.9 billion ($201,000) in the quarter, thanks to additional income from recently acquired CyberVale 3. Shares in Ascendas India Trust closed at $1.05.

See: Ascendas India Trust posts 1.42 cents DPU for 3Q

Cordlife secures 98.71% of Stemlife at close of offer

SINGAPORE (Jan 31): Cordlife Group has acquired 98.71% of Stemlife at the close of its voluntary general offer on Tuesday.

The group had made a voluntary general offer for all of the shares in Stemlife that it did not own in November 2016.

(See alsoCordlife makes offer to buy the rest of StemLife in $24.4 mil deal)

Be informed of the stories that matter

Subscribe

Be informed of the stories that matter